

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.82423396 |
| 2 | neutrophil activation involved in immune response (GO:0002283) | 5.57004552 |
| 3 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.52063721 |
| 4 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.52063721 |
| 5 | modulation by symbiont of host immune response (GO:0052553) | 5.52063721 |
| 6 | positive regulation by symbiont of host defense response (GO:0052509) | 5.52063721 |
| 7 | modulation by symbiont of host defense response (GO:0052031) | 5.52063721 |
| 8 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.52063721 |
| 9 | regulation of vitamin D biosynthetic process (GO:0060556) | 5.40864986 |
| 10 | positive regulation of interferon-alpha production (GO:0032727) | 5.39293747 |
| 11 | regulation of interferon-alpha production (GO:0032647) | 5.12443797 |
| 12 | response to peptidoglycan (GO:0032494) | 5.07969379 |
| 13 | immunoglobulin mediated immune response (GO:0016064) | 5.03459948 |
| 14 | negative regulation of interleukin-12 production (GO:0032695) | 4.68141956 |
| 15 | glycosphingolipid catabolic process (GO:0046479) | 4.57633754 |
| 16 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.43926373 |
| 17 | macrophage activation involved in immune response (GO:0002281) | 4.42730872 |
| 18 | oligosaccharide catabolic process (GO:0009313) | 4.30827469 |
| 19 | microglial cell activation (GO:0001774) | 4.28439856 |
| 20 | regulation of vitamin metabolic process (GO:0030656) | 4.26184592 |
| 21 | respiratory burst (GO:0045730) | 4.24426571 |
| 22 | cellular response to zinc ion (GO:0071294) | 4.16881886 |
| 23 | positive regulation of monocyte chemotaxis (GO:0090026) | 4.16744916 |
| 24 | eosinophil chemotaxis (GO:0048245) | 4.14224072 |
| 25 | positive regulation of type 2 immune response (GO:0002830) | 4.13241271 |
| 26 | glycolipid catabolic process (GO:0019377) | 4.10431303 |
| 27 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 4.09257157 |
| 28 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.03068629 |
| 29 | neutrophil activation (GO:0042119) | 4.00897280 |
| 30 | granulocyte activation (GO:0036230) | 4.00177421 |
| 31 | cellular response to exogenous dsRNA (GO:0071360) | 3.96512945 |
| 32 | cellular response to type I interferon (GO:0071357) | 3.95599493 |
| 33 | type I interferon signaling pathway (GO:0060337) | 3.95599493 |
| 34 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.94420085 |
| 35 | response to type I interferon (GO:0034340) | 3.93178173 |
| 36 | T-helper 1 type immune response (GO:0042088) | 3.91340414 |
| 37 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.89359523 |
| 38 | response to host immune response (GO:0052572) | 3.89359523 |
| 39 | lymphocyte chemotaxis (GO:0048247) | 3.89315652 |
| 40 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.87708302 |
| 41 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.87419920 |
| 42 | regulation of mononuclear cell migration (GO:0071675) | 3.83608729 |
| 43 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.83349276 |
| 44 | B cell mediated immunity (GO:0019724) | 3.78025481 |
| 45 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.75094537 |
| 46 | positive regulation of antigen processing and presentation (GO:0002579) | 3.72809900 |
| 47 | positive regulation of interferon-beta production (GO:0032728) | 3.71454296 |
| 48 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.69104152 |
| 49 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.68715479 |
| 50 | ceramide catabolic process (GO:0046514) | 3.66329510 |
| 51 | regulation of activation of Janus kinase activity (GO:0010533) | 3.65649777 |
| 52 | decidualization (GO:0046697) | 3.65277906 |
| 53 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.65046293 |
| 54 | response to interferon-alpha (GO:0035455) | 3.64257107 |
| 55 | eosinophil migration (GO:0072677) | 3.63295240 |
| 56 | cellular response to interferon-alpha (GO:0035457) | 3.62636718 |
| 57 | positive regulation of heat generation (GO:0031652) | 3.61769739 |
| 58 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.59487131 |
| 59 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.57382606 |
| 60 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.55996343 |
| 61 | monocyte chemotaxis (GO:0002548) | 3.53374520 |
| 62 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.53139088 |
| 63 | T cell migration (GO:0072678) | 3.52320636 |
| 64 | myeloid cell activation involved in immune response (GO:0002275) | 3.52144103 |
| 65 | macrophage activation (GO:0042116) | 3.51660399 |
| 66 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 3.50159838 |
| 67 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.50050941 |
| 68 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.49500112 |
| 69 | defense response to protozoan (GO:0042832) | 3.48707758 |
| 70 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.48052513 |
| 71 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.47586095 |
| 72 | positive regulation of mast cell degranulation (GO:0043306) | 3.47586095 |
| 73 | regulation of fever generation (GO:0031620) | 3.44912084 |
| 74 | response to host (GO:0075136) | 3.42745952 |
| 75 | response to host defenses (GO:0052200) | 3.42745952 |
| 76 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.42745952 |
| 77 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.41890874 |
| 78 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.40884472 |
| 79 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.39122165 |
| 80 | amino sugar catabolic process (GO:0046348) | 3.38224903 |
| 81 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.37662816 |
| 82 | response to muramyl dipeptide (GO:0032495) | 3.37306187 |
| 83 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.34062041 |
| 84 | positive regulation of interleukin-12 production (GO:0032735) | 3.33548662 |
| 85 | superoxide anion generation (GO:0042554) | 3.31004686 |
| 86 | regulation of monocyte chemotaxis (GO:0090025) | 3.30322003 |
| 87 | positive regulation of T-helper 1 type immune response (GO:0002827) | 3.27976273 |
| 88 | positive regulation of mast cell activation (GO:0033005) | 3.27102360 |
| 89 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 3.26485362 |
| 90 | myeloid dendritic cell differentiation (GO:0043011) | 3.25587452 |
| 91 | negative regulation of interleukin-17 production (GO:0032700) | 3.25536846 |
| 92 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 3.25105713 |
| 93 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.23355125 |
| 94 | positive regulation of lymphocyte migration (GO:2000403) | 3.22677071 |
| 95 | regulation of T-helper cell differentiation (GO:0045622) | 3.21845893 |
| 96 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 3.20945518 |
| 97 | NIK/NF-kappaB signaling (GO:0038061) | 3.20934330 |
| 98 | cellular response to interferon-beta (GO:0035458) | 3.20721637 |
| 99 | positive regulation of tissue remodeling (GO:0034105) | 3.17416432 |
| 100 | positive regulation of natural killer cell activation (GO:0032816) | 3.17387223 |
| 101 | regulation of antigen processing and presentation (GO:0002577) | 3.17349842 |
| 102 | regulation of podosome assembly (GO:0071801) | 3.16796307 |
| 103 | negative regulation of viral genome replication (GO:0045071) | 3.16370918 |
| 104 | positive regulation of T cell migration (GO:2000406) | 3.16045214 |
| 105 | cellular response to cadmium ion (GO:0071276) | 3.15673440 |
| 106 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.15576353 |
| 107 | membrane lipid catabolic process (GO:0046466) | 3.13921957 |
| 108 | reactive oxygen species biosynthetic process (GO:1903409) | 3.11856006 |
| 109 | sexual reproduction (GO:0019953) | 3.10600337 |
| 110 | lymphocyte mediated immunity (GO:0002449) | 3.10286279 |
| 111 | leukocyte mediated cytotoxicity (GO:0001909) | 3.09151603 |
| 112 | response to protozoan (GO:0001562) | 3.08798359 |
| 113 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.08774927 |
| 114 | positive regulation of T-helper cell differentiation (GO:0045624) | 3.07692991 |
| 115 | regulation of interleukin-17 production (GO:0032660) | 3.07201230 |
| 116 | regulation of RIG-I signaling pathway (GO:0039535) | 3.07183709 |
| 117 | regulation of chemokine biosynthetic process (GO:0045073) | 3.06388019 |
| 118 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.06180182 |
| 119 | regulation of memory T cell differentiation (GO:0043380) | 3.05761835 |
| 120 | positive regulation of interleukin-17 production (GO:0032740) | 3.05738595 |
| 121 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.04461031 |
| 122 | positive regulation of macrophage cytokine production (GO:0060907) | 3.02445925 |
| 123 | sphingolipid catabolic process (GO:0030149) | 3.01857465 |
| 124 | regulation of cholesterol storage (GO:0010885) | 3.01385859 |
| 125 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.99809085 |
| 126 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.99448195 |
| 127 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.99116412 |
| 128 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.98710226 |
| 129 | positive regulation of interleukin-10 production (GO:0032733) | 2.98491311 |
| 130 | myeloid dendritic cell activation (GO:0001773) | 2.98341844 |
| 131 | positive regulation of defense response to virus by host (GO:0002230) | 2.98278440 |
| 132 | natural killer cell mediated immunity (GO:0002228) | 2.97196627 |
| 133 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.97196627 |
| 134 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.96491867 |
| 135 | regulation of chronic inflammatory response (GO:0002676) | 2.96289655 |
| 136 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.96145936 |
| 137 | cellular response to interferon-gamma (GO:0071346) | 2.96143470 |
| 138 | response to thyroid hormone (GO:0097066) | 2.96089064 |
| 139 | negative regulation of interleukin-10 production (GO:0032693) | 2.95538433 |
| 140 | myeloid leukocyte activation (GO:0002274) | 2.95130782 |
| 141 | positive regulation of tumor necrosis factor production (GO:0032760) | 2.95059064 |
| 142 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.94736969 |
| 143 | response to interferon-beta (GO:0035456) | 2.94628683 |
| 144 | cellular response to lipopolysaccharide (GO:0071222) | 2.92158743 |
| 145 | adhesion of symbiont to host cell (GO:0044650) | 2.89005758 |
| 146 | virion attachment to host cell (GO:0019062) | 2.89005758 |
| 147 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.88972679 |
| 148 | regulation of interleukin-12 production (GO:0032655) | 2.88764971 |
| 149 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.88308830 |
| 150 | regulation of nitric oxide biosynthetic process (GO:0045428) | 2.83775841 |
| 151 | cellular response to molecule of bacterial origin (GO:0071219) | 2.81230071 |
| 152 | positive regulation of osteoclast differentiation (GO:0045672) | 2.78338261 |
| 153 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.77527267 |
| 154 | regulation of growth of symbiont in host (GO:0044126) | 2.77136376 |
| 155 | negative regulation of growth of symbiont in host (GO:0044130) | 2.77136376 |
| 156 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.77136376 |
| 157 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.77136376 |
| 158 | regulation of T-helper 1 type immune response (GO:0002825) | 2.73995074 |
| 159 | regulation of tyrosine phosphorylation of Stat1 protein (GO:0042510) | 2.71686832 |
| 160 | regulation of NF-kappaB import into nucleus (GO:0042345) | 2.68965165 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.72247631 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 7.67169441 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.60487718 |
| 4 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 5.08790407 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.79960688 |
| 6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.49314988 |
| 7 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.28202038 |
| 8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.96375003 |
| 9 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.73202193 |
| 10 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.57050159 |
| 11 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.15015740 |
| 12 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.05126402 |
| 13 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.99549811 |
| 14 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.79488104 |
| 15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.77149301 |
| 16 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.64284994 |
| 17 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.61989272 |
| 18 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.61605913 |
| 19 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.55156805 |
| 20 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.47052107 |
| 21 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.13724336 |
| 22 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.02606697 |
| 23 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.92057391 |
| 24 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.84281837 |
| 25 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.83464694 |
| 26 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.78079303 |
| 27 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.71657157 |
| 28 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.71349119 |
| 29 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.69825981 |
| 30 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.66071585 |
| 31 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.61896067 |
| 32 | SPI1_23127762_ChIP-Seq_K562_Human | 1.61191168 |
| 33 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.59307142 |
| 34 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.58321340 |
| 35 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.56357918 |
| 36 | MYB_26560356_Chip-Seq_TH2_Human | 1.53103494 |
| 37 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.49691613 |
| 38 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.48190414 |
| 39 | GATA1_22025678_ChIP-Seq_K562_Human | 1.47836213 |
| 40 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.46332319 |
| 41 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.43929796 |
| 42 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43354094 |
| 43 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.42833376 |
| 44 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.42372899 |
| 45 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.41997870 |
| 46 | * MAF_26560356_Chip-Seq_TH1_Human | 1.38272609 |
| 47 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.38021673 |
| 48 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.36624738 |
| 49 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.36051214 |
| 50 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.31979700 |
| 51 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.30712918 |
| 52 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.28651105 |
| 53 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.25585612 |
| 54 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.24294607 |
| 55 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20115730 |
| 56 | MYB_26560356_Chip-Seq_TH1_Human | 1.19886942 |
| 57 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.17240376 |
| 58 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.17149448 |
| 59 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.16853107 |
| 60 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.16735854 |
| 61 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.16702512 |
| 62 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.16547447 |
| 63 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.16199994 |
| 64 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13850769 |
| 65 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.13543554 |
| 66 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.13355125 |
| 67 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.12614122 |
| 68 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.12580933 |
| 69 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12470632 |
| 70 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.11773950 |
| 71 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.08607022 |
| 72 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.08459429 |
| 73 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.07753161 |
| 74 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.06337815 |
| 75 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05158995 |
| 76 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.04785602 |
| 77 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.04173363 |
| 78 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.03466696 |
| 79 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.00858723 |
| 80 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.00802003 |
| 81 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.00689574 |
| 82 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.99463389 |
| 83 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.99399700 |
| 84 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.99326992 |
| 85 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.99170350 |
| 86 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.99088295 |
| 87 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.98728632 |
| 88 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97631418 |
| 89 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97514117 |
| 90 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.96780816 |
| 91 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.96518050 |
| 92 | ATF3_27146783_Chip-Seq_COLON_Human | 0.94168974 |
| 93 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.93773907 |
| 94 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93537452 |
| 95 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.93328590 |
| 96 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.93153626 |
| 97 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.93090977 |
| 98 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.92715828 |
| 99 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.91323894 |
| 100 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.90883471 |
| 101 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.90140166 |
| 102 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.89845766 |
| 103 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.89845766 |
| 104 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.89683692 |
| 105 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.89654892 |
| 106 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.80255772 |
| 107 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.77717332 |
| 108 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.77363797 |
| 109 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.75534873 |
| 110 | UTX_26944678_Chip-Seq_JUKART_Human | 0.74664824 |
| 111 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.73910434 |
| 112 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72077886 |
| 113 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.69830818 |
| 114 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.69608300 |
| 115 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.67624596 |
| 116 | CJUN_26792858_Chip-Seq_BT549_Human | 0.66421666 |
| 117 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.65745706 |
| 118 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.64882424 |
| 119 | GATA1_19941826_ChIP-Seq_K562_Human | 0.64689383 |
| 120 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.62997041 |
| 121 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.62210240 |
| 122 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.62117457 |
| 123 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.61597907 |
| 124 | GATA2_19941826_ChIP-Seq_K562_Human | 0.61488522 |
| 125 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.60880002 |
| 126 | MAF_26560356_Chip-Seq_TH2_Human | 0.60572156 |
| 127 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.58739698 |
| 128 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.57432843 |
| 129 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.57432843 |
| 130 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.55979484 |
| 131 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.54657332 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 5.32128600 |
| 2 | MP0002148_abnormal_hypersensitivity_rea | 4.20410234 |
| 3 | MP0003436_decreased_susceptibility_to | 4.11037117 |
| 4 | MP0009785_altered_susceptibility_to | 4.05696055 |
| 5 | MP0005058_abnormal_lysosome_morphology | 3.45165092 |
| 6 | MP0006082_CNS_inflammation | 3.39502971 |
| 7 | MP0005000_abnormal_immune_tolerance | 3.34622488 |
| 8 | MP0002419_abnormal_innate_immunity | 3.32908690 |
| 9 | MP0005671_abnormal_response_to | 3.28257540 |
| 10 | MP0005025_abnormal_response_to | 3.15308742 |
| 11 | MP0001790_abnormal_immune_system | 3.07348952 |
| 12 | MP0005387_immune_system_phenotype | 3.07348952 |
| 13 | MP0003303_peritoneal_inflammation | 2.92257163 |
| 14 | MP0003724_increased_susceptibility_to | 2.92134920 |
| 15 | MP0000685_abnormal_immune_system | 2.79129541 |
| 16 | MP0004510_myositis | 2.72541789 |
| 17 | MP0002452_abnormal_antigen_presenting | 2.70866275 |
| 18 | MP0001800_abnormal_humoral_immune | 2.65404132 |
| 19 | MP0002723_abnormal_immune_serum | 2.55142679 |
| 20 | MP0002139_abnormal_hepatobiliary_system | 2.31334675 |
| 21 | MP0001533_abnormal_skeleton_physiology | 2.28240400 |
| 22 | MP0005451_abnormal_body_composition | 2.24854170 |
| 23 | MP0001819_abnormal_immune_cell | 2.22068327 |
| 24 | MP0002420_abnormal_adaptive_immunity | 2.17817228 |
| 25 | MP0009840_abnormal_foam_cell | 2.17377572 |
| 26 | MP0003806_abnormal_nucleotide_metabolis | 2.10399054 |
| 27 | MP0009764_decreased_sensitivity_to | 1.96651545 |
| 28 | MP0001845_abnormal_inflammatory_respons | 1.93207295 |
| 29 | MP0001853_heart_inflammation | 1.90266836 |
| 30 | MP0005464_abnormal_platelet_physiology | 1.87669277 |
| 31 | MP0002405_respiratory_system_inflammati | 1.84219815 |
| 32 | MP0003075_altered_response_to | 1.83394174 |
| 33 | MP0008469_abnormal_protein_level | 1.81832713 |
| 34 | MP0005310_abnormal_salivary_gland | 1.80888948 |
| 35 | MP0000343_altered_response_to | 1.80029874 |
| 36 | MP0010155_abnormal_intestine_physiology | 1.68632072 |
| 37 | MP0004947_skin_inflammation | 1.68027131 |
| 38 | MP0003448_altered_tumor_morphology | 1.66461486 |
| 39 | MP0006054_spinal_hemorrhage | 1.63750380 |
| 40 | MP0003950_abnormal_plasma_membrane | 1.62555418 |
| 41 | MP0003191_abnormal_cellular_cholesterol | 1.61252392 |
| 42 | MP0009333_abnormal_splenocyte_physiolog | 1.58756117 |
| 43 | MP0008260_abnormal_autophagy | 1.58271427 |
| 44 | MP0003690_abnormal_glial_cell | 1.57131894 |
| 45 | MP0002006_tumorigenesis | 1.50887680 |
| 46 | MP0000716_abnormal_immune_system | 1.50179692 |
| 47 | MP0002998_abnormal_bone_remodeling | 1.46607718 |
| 48 | MP0003172_abnormal_lysosome_physiology | 1.42340374 |
| 49 | MP0005166_decreased_susceptibility_to | 1.42206784 |
| 50 | MP0003656_abnormal_erythrocyte_physiolo | 1.40672056 |
| 51 | MP0000604_amyloidosis | 1.39350592 |
| 52 | MP0005167_abnormal_blood-brain_barrier | 1.38939893 |
| 53 | MP0004782_abnormal_surfactant_physiolog | 1.36826759 |
| 54 | MP0002398_abnormal_bone_marrow | 1.33554212 |
| 55 | MP0000858_altered_metastatic_potential | 1.32794249 |
| 56 | MP0005023_abnormal_wound_healing | 1.29682829 |
| 57 | MP0002277_abnormal_respiratory_mucosa | 1.28292833 |
| 58 | MP0002837_dystrophic_cardiac_calcinosis | 1.24178118 |
| 59 | MP0009278_abnormal_bone_marrow | 1.23877563 |
| 60 | MP0002166_altered_tumor_susceptibility | 1.21760799 |
| 61 | MP0002429_abnormal_blood_cell | 1.16190416 |
| 62 | MP0000689_abnormal_spleen_morphology | 1.14977478 |
| 63 | MP0009763_increased_sensitivity_to | 1.11701607 |
| 64 | MP0002138_abnormal_hepatobiliary_system | 1.11279772 |
| 65 | MP0003329_amyloid_beta_deposits | 1.11108968 |
| 66 | MP0005164_abnormal_response_to | 1.09526667 |
| 67 | MP0003828_pulmonary_edema | 1.07119001 |
| 68 | MP0005390_skeleton_phenotype | 1.06040377 |
| 69 | MP0010234_abnormal_vibrissa_follicle | 1.05400367 |
| 70 | MP0009765_abnormal_xenobiotic_induced | 1.05328150 |
| 71 | MP0001545_abnormal_hematopoietic_system | 1.04821763 |
| 72 | MP0005397_hematopoietic_system_phenotyp | 1.04821763 |
| 73 | MP0002722_abnormal_immune_system | 1.02637281 |
| 74 | MP0005165_increased_susceptibility_to | 0.99227345 |
| 75 | MP0003186_abnormal_redox_activity | 0.96011674 |
| 76 | MP0000371_diluted_coat_color | 0.90337116 |
| 77 | MP0005666_abnormal_adipose_tissue | 0.89077794 |
| 78 | MP0002877_abnormal_melanocyte_morpholog | 0.88764729 |
| 79 | MP0005410_abnormal_fertilization | 0.87900825 |
| 80 | MP0003646_muscle_fatigue | 0.86327008 |
| 81 | MP0010307_abnormal_tumor_latency | 0.81784954 |
| 82 | MP0005076_abnormal_cell_differentiation | 0.79928744 |
| 83 | MP0000249_abnormal_blood_vessel | 0.79791825 |
| 84 | MP0001727_abnormal_embryo_implantation | 0.79593166 |
| 85 | MP0003300_gastrointestinal_ulcer | 0.77833056 |
| 86 | MP0002136_abnormal_kidney_physiology | 0.75063634 |
| 87 | MP0004883_abnormal_blood_vessel | 0.72769200 |
| 88 | MP0008004_abnormal_stomach_pH | 0.72443936 |
| 89 | MP0001851_eye_inflammation | 0.72346308 |
| 90 | MP0001849_ear_inflammation | 0.70459277 |
| 91 | MP0001216_abnormal_epidermal_layer | 0.69282352 |
| 92 | MP0002254_reproductive_system_inflammat | 0.69148978 |
| 93 | MP0005257_abnormal_intraocular_pressure | 0.68679977 |
| 94 | MP0002933_joint_inflammation | 0.68078174 |
| 95 | MP0005647_abnormal_sex_gland | 0.67553962 |
| 96 | MP0000569_abnormal_digit_pigmentation | 0.66966583 |
| 97 | MP0008874_decreased_physiological_sensi | 0.65957853 |
| 98 | MP0010352_gastrointestinal_tract_polyps | 0.64582300 |
| 99 | MP0003566_abnormal_cell_adhesion | 0.64465176 |
| 100 | MP0003705_abnormal_hypodermis_morpholog | 0.64057894 |
| 101 | MP0008438_abnormal_cutaneous_collagen | 0.64039745 |
| 102 | MP0003195_calcinosis | 0.63500283 |
| 103 | MP0003795_abnormal_bone_structure | 0.63142244 |
| 104 | MP0000920_abnormal_myelination | 0.61445036 |
| 105 | MP0003634_abnormal_glial_cell | 0.61330291 |
| 106 | MP0003183_abnormal_peptide_metabolism | 0.61297349 |
| 107 | MP0005375_adipose_tissue_phenotype | 0.60082777 |
| 108 | MP0002295_abnormal_pulmonary_circulatio | 0.58738486 |
| 109 | MP0005595_abnormal_vascular_smooth | 0.58378519 |
| 110 | MP0010386_abnormal_urinary_bladder | 0.56798963 |
| 111 | MP0003763_abnormal_thymus_physiology | 0.55647552 |
| 112 | MP0005174_abnormal_tail_pigmentation | 0.54828059 |
| 113 | MP0003279_aneurysm | 0.54234802 |
| 114 | MP0000609_abnormal_liver_physiology | 0.51539827 |
| 115 | MP0000767_abnormal_smooth_muscle | 0.50583673 |
| 116 | MP0008873_increased_physiological_sensi | 0.49815182 |
| 117 | MP0002332_abnormal_exercise_endurance | 0.49425763 |
| 118 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.48861043 |
| 119 | MP0003091_abnormal_cell_migration | 0.48370387 |
| 120 | MP0003453_abnormal_keratinocyte_physiol | 0.48215266 |
| 121 | MP0001542_abnormal_bone_strength | 0.47450947 |
| 122 | MP0005319_abnormal_enzyme/_coenzyme | 0.47281549 |
| 123 | MP0004130_abnormal_muscle_cell | 0.46825560 |
| 124 | MP0002693_abnormal_pancreas_physiology | 0.45077466 |
| 125 | MP0002090_abnormal_vision | 0.44848487 |
| 126 | MP0004808_abnormal_hematopoietic_stem | 0.44564851 |
| 127 | MP0001873_stomach_inflammation | 0.43606960 |
| 128 | MP0000465_gastrointestinal_hemorrhage | 0.42769792 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 7.81660313 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 7.39177000 |
| 3 | Systemic lupus erythematosus (HP:0002725) | 7.09611061 |
| 4 | Eczematoid dermatitis (HP:0000976) | 6.82461852 |
| 5 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.76710058 |
| 6 | Mediastinal lymphadenopathy (HP:0100721) | 4.91103205 |
| 7 | Glomerulonephritis (HP:0000099) | 4.85506964 |
| 8 | Abnormality of macrophages (HP:0004311) | 4.67344001 |
| 9 | Recurrent skin infections (HP:0001581) | 4.41555786 |
| 10 | Gingivitis (HP:0000230) | 4.35665238 |
| 11 | Vacuolated lymphocytes (HP:0001922) | 4.33026995 |
| 12 | Autoimmune thrombocytopenia (HP:0001973) | 4.30965790 |
| 13 | Thick nail (HP:0001805) | 4.08739215 |
| 14 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.80539936 |
| 15 | Pustule (HP:0200039) | 3.80444978 |
| 16 | Increased cerebral lipofuscin (HP:0011813) | 3.68551606 |
| 17 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.62206469 |
| 18 | Abnormality of complement system (HP:0005339) | 3.58189345 |
| 19 | Stomatitis (HP:0010280) | 3.57189308 |
| 20 | Recurrent fungal infections (HP:0002841) | 3.55797661 |
| 21 | Neurofibrillary tangles (HP:0002185) | 3.50196179 |
| 22 | Increased IgM level (HP:0003496) | 3.48172443 |
| 23 | Mutism (HP:0002300) | 3.48031227 |
| 24 | Prostate neoplasm (HP:0100787) | 3.47565403 |
| 25 | Axonal loss (HP:0003447) | 3.46101935 |
| 26 | Chronic obstructive pulmonary disease (HP:0006510) | 3.44844294 |
| 27 | Obstructive lung disease (HP:0006536) | 3.44844294 |
| 28 | Recurrent viral infections (HP:0004429) | 3.40330326 |
| 29 | Basal ganglia calcification (HP:0002135) | 3.37927317 |
| 30 | Disinhibition (HP:0000734) | 3.36621967 |
| 31 | Periodontitis (HP:0000704) | 3.34972649 |
| 32 | Nuclear cataract (HP:0100018) | 3.33991973 |
| 33 | Osteolytic defects of the hand bones (HP:0009699) | 3.31954650 |
| 34 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.31954650 |
| 35 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.25961784 |
| 36 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.25961784 |
| 37 | Abnormality of glycolipid metabolism (HP:0010969) | 3.25961784 |
| 38 | Complement deficiency (HP:0004431) | 3.23667402 |
| 39 | Vasculitis (HP:0002633) | 3.23529935 |
| 40 | Nephritis (HP:0000123) | 3.22165489 |
| 41 | Dysostosis multiplex (HP:0000943) | 3.21068652 |
| 42 | Gastrointestinal infarctions (HP:0005244) | 3.20490962 |
| 43 | Myositis (HP:0100614) | 3.19947453 |
| 44 | Orchitis (HP:0100796) | 3.19844280 |
| 45 | Cellulitis (HP:0100658) | 3.18047894 |
| 46 | Apathy (HP:0000741) | 3.16984964 |
| 47 | Interstitial pulmonary disease (HP:0006530) | 3.12207675 |
| 48 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.12185384 |
| 49 | Diminished motivation (HP:0000745) | 3.11756477 |
| 50 | Metaphyseal irregularity (HP:0003025) | 3.09855741 |
| 51 | Retrobulbar optic neuritis (HP:0100654) | 3.00446028 |
| 52 | Optic neuritis (HP:0100653) | 3.00446028 |
| 53 | Increased serum ferritin (HP:0003281) | 2.97994462 |
| 54 | Recurrent pneumonia (HP:0006532) | 2.87292094 |
| 55 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.80673446 |
| 56 | Recurrent cutaneous fungal infections (HP:0011370) | 2.80673446 |
| 57 | Premature loss of primary teeth (HP:0006323) | 2.75688850 |
| 58 | Urticaria (HP:0001025) | 2.71866496 |
| 59 | Pulmonary infiltrates (HP:0002113) | 2.67988593 |
| 60 | Osteomyelitis (HP:0002754) | 2.67582536 |
| 61 | Recurrent lower respiratory tract infections (HP:0002783) | 2.57235869 |
| 62 | Meningitis (HP:0001287) | 2.56711411 |
| 63 | Amyloidosis (HP:0011034) | 2.54198693 |
| 64 | Tetraparesis (HP:0002273) | 2.52769346 |
| 65 | Hypergammaglobulinemia (HP:0010702) | 2.50707771 |
| 66 | Colitis (HP:0002583) | 2.45266007 |
| 67 | Myocardial infarction (HP:0001658) | 2.40115997 |
| 68 | Petechiae (HP:0000967) | 2.39977435 |
| 69 | Progressive visual loss (HP:0000529) | 2.38654629 |
| 70 | Hepatosplenomegaly (HP:0001433) | 2.37628579 |
| 71 | Poor head control (HP:0002421) | 2.37374881 |
| 72 | Cerebral inclusion bodies (HP:0100314) | 2.37247913 |
| 73 | Progressive neurologic deterioration (HP:0002344) | 2.37177450 |
| 74 | Agnosia (HP:0010524) | 2.36934661 |
| 75 | Neuronal loss in central nervous system (HP:0002529) | 2.33699709 |
| 76 | Purpura (HP:0000979) | 2.31920353 |
| 77 | Joint hemorrhage (HP:0005261) | 2.28676777 |
| 78 | Protuberant abdomen (HP:0001538) | 2.26310793 |
| 79 | Gangrene (HP:0100758) | 2.26285271 |
| 80 | Spontaneous hematomas (HP:0007420) | 2.25865150 |
| 81 | Thin bony cortex (HP:0002753) | 2.25512396 |
| 82 | Hematochezia (HP:0002573) | 2.23343002 |
| 83 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.22358958 |
| 84 | Abnormality of iron homeostasis (HP:0011031) | 2.22089850 |
| 85 | Mucopolysacchariduria (HP:0008155) | 2.21737748 |
| 86 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.21737748 |
| 87 | Abnormality of the costochondral junction (HP:0000919) | 2.21609849 |
| 88 | Chronic otitis media (HP:0000389) | 2.21347509 |
| 89 | Bone pain (HP:0002653) | 2.17371295 |
| 90 | Leukocytosis (HP:0001974) | 2.16330779 |
| 91 | Arterial thrombosis (HP:0004420) | 2.15530590 |
| 92 | Generalized aminoaciduria (HP:0002909) | 2.13732853 |
| 93 | Asymmetric septal hypertrophy (HP:0001670) | 2.12770979 |
| 94 | Abnormality of the prostate (HP:0008775) | 2.12539034 |
| 95 | Hypertensive crisis (HP:0100735) | 2.10128556 |
| 96 | Agammaglobulinemia (HP:0004432) | 2.09646212 |
| 97 | Eosinophilia (HP:0001880) | 2.09449456 |
| 98 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.09033887 |
| 99 | Hemoptysis (HP:0002105) | 2.07753823 |
| 100 | Inappropriate behavior (HP:0000719) | 2.07248207 |
| 101 | Pathologic fracture (HP:0002756) | 2.06076836 |
| 102 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.04954947 |
| 103 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.02946003 |
| 104 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.02946003 |
| 105 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.02946003 |
| 106 | Dementia (HP:0000726) | 2.01593470 |
| 107 | Supranuclear gaze palsy (HP:0000605) | 1.98215293 |
| 108 | Skin ulcer (HP:0200042) | 1.97804073 |
| 109 | Personality changes (HP:0000751) | 1.96417033 |
| 110 | Keratoconjunctivitis sicca (HP:0001097) | 1.96204051 |
| 111 | Prolonged neonatal jaundice (HP:0006579) | 1.96095169 |
| 112 | Amaurosis fugax (HP:0100576) | 1.95860077 |
| 113 | Gingival bleeding (HP:0000225) | 1.94889981 |
| 114 | Upper motor neuron abnormality (HP:0002127) | 1.93264415 |
| 115 | Anorexia (HP:0002039) | 1.90505369 |
| 116 | Polyneuropathy (HP:0001271) | 1.90163480 |
| 117 | Inflammation of the large intestine (HP:0002037) | 1.89505737 |
| 118 | Retinal atrophy (HP:0001105) | 1.88723725 |
| 119 | Peripheral demyelination (HP:0011096) | 1.88386421 |
| 120 | Neoplasm of head and neck (HP:0012288) | 1.85948545 |
| 121 | Esophageal neoplasm (HP:0100751) | 1.85948545 |
| 122 | Sepsis (HP:0100806) | 1.83873664 |
| 123 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.83431211 |
| 124 | Arthralgia (HP:0002829) | 1.81893519 |
| 125 | Nausea (HP:0002018) | 1.81055841 |
| 126 | Abnormality of the pericardium (HP:0001697) | 1.79534185 |
| 127 | Joint swelling (HP:0001386) | 1.78733166 |
| 128 | Autoimmune hemolytic anemia (HP:0001890) | 1.78367392 |
| 129 | Vertebral compression fractures (HP:0002953) | 1.77526945 |
| 130 | Cardiomegaly (HP:0001640) | 1.76873028 |
| 131 | Loss of speech (HP:0002371) | 1.76781970 |
| 132 | Glomerulopathy (HP:0100820) | 1.76189684 |
| 133 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.75808040 |
| 134 | J-shaped sella turcica (HP:0002680) | 1.75089150 |
| 135 | Xanthomatosis (HP:0000991) | 1.74484277 |
| 136 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.70749605 |
| 137 | Keratoconjunctivitis (HP:0001096) | 1.70703422 |
| 138 | Cervical subluxation (HP:0003308) | 1.70348458 |
| 139 | Hyperparathyroidism (HP:0000843) | 1.69360679 |
| 140 | Cutaneous melanoma (HP:0012056) | 1.65509174 |
| 141 | Conjunctival telangiectasia (HP:0000524) | 1.63369975 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 4.86389848 |
| 2 | RIPK4 | 4.31400351 |
| 3 | DDR2 | 4.05412561 |
| 4 | TYK2 | 3.96614245 |
| 5 | TBK1 | 3.54871940 |
| 6 | BLK | 3.49923033 |
| 7 | PBK | 3.14666654 |
| 8 | IRAK4 | 3.02058628 |
| 9 | IKBKE | 2.70841336 |
| 10 | IRAK3 | 2.58417723 |
| 11 | IKBKB | 2.49392519 |
| 12 | JAK1 | 2.38298208 |
| 13 | JAK3 | 2.32076404 |
| 14 | ERN1 | 2.14077607 |
| 15 | TGFBR2 | 2.12529898 |
| 16 | MAP4K1 | 2.05113823 |
| 17 | TXK | 1.98323155 |
| 18 | PIM2 | 1.96021737 |
| 19 | MAP3K9 | 1.94849724 |
| 20 | KIT | 1.84925064 |
| 21 | GRK7 | 1.83561466 |
| 22 | STK24 | 1.65705787 |
| 23 | HCK | 1.64404957 |
| 24 | PRPF4B | 1.63117835 |
| 25 | BMPR2 | 1.62486628 |
| 26 | CSK | 1.59687244 |
| 27 | CHUK | 1.50704171 |
| 28 | SYK | 1.46076032 |
| 29 | MAP3K13 | 1.43735985 |
| 30 | NEK9 | 1.42949295 |
| 31 | MST4 | 1.39357505 |
| 32 | BTK | 1.39340363 |
| 33 | EIF2AK2 | 1.38748958 |
| 34 | LYN | 1.36068186 |
| 35 | CSF1R | 1.35562379 |
| 36 | NME2 | 1.30941585 |
| 37 | JAK2 | 1.30896259 |
| 38 | TEC | 1.29880905 |
| 39 | EPHB1 | 1.27401825 |
| 40 | ZAP70 | 1.23769427 |
| 41 | FGR | 1.13924550 |
| 42 | TESK1 | 1.12289564 |
| 43 | CDC42BPA | 1.11437616 |
| 44 | YES1 | 1.06557161 |
| 45 | EPHB2 | 1.06238475 |
| 46 | ABL2 | 1.04966463 |
| 47 | KSR2 | 1.01696667 |
| 48 | MATK | 1.01046058 |
| 49 | LCK | 1.00001399 |
| 50 | PIM1 | 0.96162446 |
| 51 | LATS2 | 0.95802205 |
| 52 | ACVR1B | 0.95794429 |
| 53 | MAP3K5 | 0.92511219 |
| 54 | CLK1 | 0.90387024 |
| 55 | STK10 | 0.85331163 |
| 56 | PAK4 | 0.84371833 |
| 57 | ADRBK2 | 0.83937296 |
| 58 | FES | 0.83351759 |
| 59 | FGFR4 | 0.83254795 |
| 60 | ARAF | 0.83024610 |
| 61 | BMX | 0.82758986 |
| 62 | TAOK3 | 0.81310886 |
| 63 | PRKCD | 0.79675801 |
| 64 | LIMK1 | 0.79444285 |
| 65 | PDGFRA | 0.78557172 |
| 66 | RIPK1 | 0.77492960 |
| 67 | STK4 | 0.75762147 |
| 68 | MAP2K3 | 0.74945479 |
| 69 | EPHA3 | 0.74291357 |
| 70 | ITK | 0.73905090 |
| 71 | MAP3K11 | 0.72706113 |
| 72 | MARK3 | 0.70022094 |
| 73 | BRAF | 0.69028723 |
| 74 | MOS | 0.66293716 |
| 75 | PKN2 | 0.61627784 |
| 76 | EGFR | 0.60652621 |
| 77 | RAF1 | 0.57952274 |
| 78 | ABL1 | 0.57811141 |
| 79 | MAP3K3 | 0.56091117 |
| 80 | ERBB3 | 0.54851964 |
| 81 | FGFR3 | 0.54566001 |
| 82 | TESK2 | 0.54326608 |
| 83 | CAMKK2 | 0.53509969 |
| 84 | MAP3K1 | 0.53468375 |
| 85 | TRPM7 | 0.53030832 |
| 86 | PRKCQ | 0.51863458 |
| 87 | ILK | 0.50952180 |
| 88 | IRAK1 | 0.49832872 |
| 89 | MST1R | 0.49541091 |
| 90 | GSK3A | 0.46848821 |
| 91 | KSR1 | 0.46000756 |
| 92 | TRIB3 | 0.45017211 |
| 93 | MAP2K6 | 0.44704044 |
| 94 | TAOK2 | 0.44240711 |
| 95 | CDK6 | 0.43513156 |
| 96 | MAPKAPK2 | 0.42348539 |
| 97 | RPS6KA4 | 0.42144035 |
| 98 | ICK | 0.41420215 |
| 99 | PIK3CG | 0.37061554 |
| 100 | DAPK3 | 0.36840673 |
| 101 | MAP3K10 | 0.34563769 |
| 102 | PDK2 | 0.33494396 |
| 103 | DYRK1B | 0.33449913 |
| 104 | MAP3K12 | 0.33355775 |
| 105 | MAP3K8 | 0.32826768 |
| 106 | IGF1R | 0.32410048 |
| 107 | PAK1 | 0.31672576 |
| 108 | TAOK1 | 0.31195206 |
| 109 | RPS6KL1 | 0.30415656 |
| 110 | RPS6KC1 | 0.30415656 |
| 111 | BCKDK | 0.29751616 |
| 112 | CAMKK1 | 0.29294615 |
| 113 | SIK3 | 0.29105349 |
| 114 | TYRO3 | 0.27646554 |
| 115 | CDK18 | 0.26695832 |
| 116 | TTN | 0.26259131 |
| 117 | CDK15 | 0.26072109 |
| 118 | TGFBR1 | 0.24342058 |
| 119 | FYN | 0.23521243 |
| 120 | CDK11A | 0.23440001 |
| 121 | CDK14 | 0.23410743 |
| 122 | LRRK2 | 0.22151178 |
| 123 | IRAK2 | 0.21411456 |
| 124 | PDK1 | 0.20860808 |
| 125 | INSR | 0.20212458 |
| 126 | PKN1 | 0.19562154 |
| 127 | SIK2 | 0.19478665 |
| 128 | RPS6KA6 | 0.18394919 |
| 129 | CAMK1D | 0.17544077 |
| 130 | STK3 | 0.17275433 |
| 131 | PDPK1 | 0.16558555 |
| 132 | SRC | 0.15402551 |
| 133 | MAPK4 | 0.14934998 |
| 134 | PDGFRB | 0.13067135 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 4.02905483 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.41157656 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 3.33684190 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 3.22103453 |
| 5 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 3.01232080 |
| 6 | Pertussis_Homo sapiens_hsa05133 | 2.57012423 |
| 7 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.53579789 |
| 8 | Legionellosis_Homo sapiens_hsa05134 | 2.51051086 |
| 9 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.43998413 |
| 10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.35189994 |
| 11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.28307261 |
| 12 | Malaria_Homo sapiens_hsa05144 | 2.27052144 |
| 13 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.18336408 |
| 14 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.16265495 |
| 15 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.14723407 |
| 16 | Tuberculosis_Homo sapiens_hsa05152 | 2.14590688 |
| 17 | Measles_Homo sapiens_hsa05162 | 2.09409638 |
| 18 | Asthma_Homo sapiens_hsa05310 | 2.06948403 |
| 19 | Lysosome_Homo sapiens_hsa04142 | 2.03468280 |
| 20 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.02313083 |
| 21 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.95323228 |
| 22 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.93321063 |
| 23 | Influenza A_Homo sapiens_hsa05164 | 1.91435997 |
| 24 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.65265245 |
| 25 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.65189026 |
| 26 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.62214125 |
| 27 | Phagosome_Homo sapiens_hsa04145 | 1.62211237 |
| 28 | Salmonella infection_Homo sapiens_hsa05132 | 1.61567026 |
| 29 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.61494402 |
| 30 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.57858967 |
| 31 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.54626683 |
| 32 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.52010625 |
| 33 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.50696137 |
| 34 | Other glycan degradation_Homo sapiens_hsa00511 | 1.50415481 |
| 35 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.48677964 |
| 36 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.40904396 |
| 37 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.39122768 |
| 38 | Prion diseases_Homo sapiens_hsa05020 | 1.36413560 |
| 39 | Apoptosis_Homo sapiens_hsa04210 | 1.35599205 |
| 40 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.26046334 |
| 41 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.24849263 |
| 42 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.23563338 |
| 43 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.19911038 |
| 44 | Viral myocarditis_Homo sapiens_hsa05416 | 1.19310595 |
| 45 | Shigellosis_Homo sapiens_hsa05131 | 1.13482174 |
| 46 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.13316598 |
| 47 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.09318722 |
| 48 | Galactose metabolism_Homo sapiens_hsa00052 | 1.02425889 |
| 49 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.02166167 |
| 50 | Bladder cancer_Homo sapiens_hsa05219 | 0.97214284 |
| 51 | Hepatitis C_Homo sapiens_hsa05160 | 0.95937849 |
| 52 | Hepatitis B_Homo sapiens_hsa05161 | 0.93173330 |
| 53 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.88948229 |
| 54 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.88032496 |
| 55 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.85902450 |
| 56 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.84010750 |
| 57 | Amoebiasis_Homo sapiens_hsa05146 | 0.84004551 |
| 58 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.80327840 |
| 59 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.78987461 |
| 60 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.74185343 |
| 61 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.73557027 |
| 62 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.65779454 |
| 63 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.62254971 |
| 64 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.58036348 |
| 65 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.54173458 |
| 66 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.49099375 |
| 67 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.46438057 |
| 68 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.46422277 |
| 69 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.46273209 |
| 70 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.46138643 |
| 71 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.45829792 |
| 72 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.44681180 |
| 73 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.43198111 |
| 74 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.42915564 |
| 75 | Mineral absorption_Homo sapiens_hsa04978 | 0.42690483 |
| 76 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.42191202 |
| 77 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.42070115 |
| 78 | Platelet activation_Homo sapiens_hsa04611 | 0.41542573 |
| 79 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.40239985 |
| 80 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.40217173 |
| 81 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.39384079 |
| 82 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.38252870 |
| 83 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.37363843 |
| 84 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.36110774 |
| 85 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.36040892 |
| 86 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.35182796 |
| 87 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.32477935 |
| 88 | Endocytosis_Homo sapiens_hsa04144 | 0.32009376 |
| 89 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.31726651 |
| 90 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.30014685 |
| 91 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.24973933 |
| 92 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.22904204 |
| 93 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.22803386 |
| 94 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.22645597 |
| 95 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.22351834 |
| 96 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.21102566 |
| 97 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.21030595 |
| 98 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.19778468 |
| 99 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.19041777 |
| 100 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.17637640 |
| 101 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.16830642 |
| 102 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.14905601 |
| 103 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.14686832 |
| 104 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.14399906 |
| 105 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.13899496 |
| 106 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.13852038 |
| 107 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.13429916 |
| 108 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.12739981 |
| 109 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.12598353 |
| 110 | HTLV-I infection_Homo sapiens_hsa05166 | 0.12292979 |
| 111 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.10019913 |
| 112 | Insulin resistance_Homo sapiens_hsa04931 | 0.08029071 |
| 113 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.07441514 |
| 114 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.01994350 |
| 115 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.01696211 |

